Dynamic endocannabinoid-mediated neuromodulation of retinal circadian circuitry

Deepak Kumar, Bareera Khan, Yagmur Okcay, Çağıl Önal Sis, Aya Abdallah, Fiona Murray, Ashish Sharma, Maiko Uemura, Rajeev Taliyan, Thomas Heinbockel, Shafiqur Rahman, Rohit Goyal

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

Circadian rhythms are biological rhythms that originate from the “master circadian clock,” called the suprachiasmatic nucleus (SCN). SCN orchestrates the circadian rhythms using light as a chief zeitgeber, enabling humans to synchronize their daily physio-behavioral activities with the Earth's light-dark cycle. However, chronic/ irregular photic disturbances from the retina via the retinohypothalamic tract (RHT) can disrupt the amplitude and the expression of clock genes, such as the period circadian clock 2, causing circadian rhythm disruption (CRd) and associated neuropathologies. The present review discusses neuromodulation across the RHT originating from retinal photic inputs and modulation offered by endocannabinoids as a function of mitigation of the CRd and associated neuro-dysfunction. Literature indicates that cannabinoid agonists alleviate the SCN's ability to get entrained to light by modulating the activity of its chief neurotransmitter, i.e., γ-aminobutyric acid, thus preventing light-induced disruption of activity rhythms in laboratory animals. In the retina, endocannabinoid signaling modulates the overall gain of the retinal ganglion cells by regulating the membrane currents (Ca2+, K+, and Cl- channels) and glutamatergic neurotransmission of photoreceptors and bipolar cells. Additionally, endocannabinoids signalling also regulate the high-voltage-activated Ca2+ channels to mitigate the retinal ganglion cells and intrinsically photosensitive retinal ganglion cells-mediated glutamate release in the SCN, thus regulating the RHT-mediated light stimulation of SCN neurons to prevent excitotoxicity. As per the literature, cannabinoid receptors 1 and 2 are becoming newer targets in drug discovery paradigms, and the involvement of endocannabinoids in light-induced CRd through the RHT may possibly mitigate severe neuropathologies.

Original languageEnglish
Article number102401
JournalAgeing Research Reviews
Volume99
DOIs
StatePublished - Aug 2024
Externally publishedYes

Keywords

  • Circadian
  • Endocannabinoid
  • Retina
  • Retinohypothalamic
  • Suprachiasmatic

Fingerprint

Dive into the research topics of 'Dynamic endocannabinoid-mediated neuromodulation of retinal circadian circuitry'. Together they form a unique fingerprint.

Cite this